MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Burden and management of tardive dyskinesia (TD): a cross-sectional international survey study to assess the perceptions and experiences of patients with TD

    R. Ribalov, A. Yaari, A. Peyser Levin, A. Yang, D. Horchi, E. Berjonneau, P. Le Calvé, M. Tian, S. Reshef, S. Reed (Tel-Aviv-Yafo, Israel)

    Objective: To assess patient perceptions of and experiences with TD and its impact on their daily functioning and quality of life (QoL). Background: There is…
  • 2023 International Congress

    Utility of neurophysiological markers in clinical management of subthalamic nucleus (STN) deep brain stimulation (DBS) in Parkinson’s disease (PD)-a case report.

    K. Markopoulou, P. Warnke (Evanston, USA)

    Objective: Use local field potentials (LFP) to inform longitudinal clinical decision making. Background: Genetic status, clinical and stimulation parameters affect outcomes in PD STN DBS.…
  • 2023 International Congress

    Clinical-based diagnosis and self-reported Parkinson’s disease in a population-based sample in southern Brazil

    G. Pereira, N. Soares, G. Marconi, C. Sangali, I. Pasuch, C. Bertocchi, N. Bruscato, J. Senger, A. Schumacher-Schuh, C. Rieder (Porto Alegre, Brazil)

    Objective: To report the frequency of self-reported PD and the diagnostic evaluation performed by clinical neurologists in a population-based cohort from south Brazil. Background: It…
  • 2023 International Congress

    Challenges with oral anti-parkinsonian medications and opportunities with continuous subcutaneous infusion (CSCI) of foslevodopa/foscarbidopa (LDP/CDP) for treatment of advanced Parkinson’s Disease (aPD)

    J. Aldred, M. Soileau, C. Yan, T. Brion, A. Bellenger, J. Suh, C. O'Donnell, P. Kukreja, M. Facheris, A. Shewale, R. Kumar (Spokane, USA)

    Objective: To understand people with Parkinson’s (PwP) experience with their advancing disease and identify factors for PwP to initiate and continue on LDP/CDP as treatment…
  • 2023 International Congress

    The Roche ‘End-to-End Matrix’ for Patient-Centric Drug Discovery and Development – Focus on Parkinson’s disease

    A. Paehler, A. Stepan, E. Mracsko, K. Taylor, B. Zinnhardt, H. Binch, L. Gobbi, T. Luebbers, A. Olivares, R. Rodriguez Sarmiento, U. Grether, S. Dudal, G. Pagano (Basel, Switzerland)

    Objective: To develop an ‘End-to-End Matrix’ for Patient-Centric Drug Discovery and Development to increase the probability of success of clinical trials in Parkinson’s disease. Background:…
  • 2023 International Congress

    Effects of a rhythmic auditory stimulation-enhanced walking program on Veterans with Parkinson’s disease with and without subthalamic nucleus deep brain stimulation.

    A. Umbarger, S. Kletzel, S. Walker, C. Jelinek, C. Kestner, K. Krese, B. Mcreavy, T. Bender Pape, F. Weaver, K. Colletta (Gary, USA)

    Objective: Describe outcomes from a 12-week home-based rhythmic auditory stimulation (RAS)-enhanced walking program completed by Veterans with Parkinson’s disease (PD); 1 with subthalamic nucleus deep brain stimulation…
  • 2023 International Congress

    The PD-Ballet study: a randomised controlled, single-blinded trial of dance therapy for Parkinson’s, baseline characteristics of the study cohort

    A. Podlewska, L. Batzu, J. Staunton, P. Tall, V. Leta, M. Uribe Mz-Recaman, F. Derbyshire-Fox, A. Hartley, T. Soukup, R. Davis, N. Sevdalis, A. Healey, I. Bakolis, C. Pariante, A. Woods, K. Ray Chaudhuri (London, United Kingdom)

    Objective: To describe baseline characteristics of the cohort of participants recruited to a world-first randomised controlled single blind trial of ballet-based dance intervention for holistic…
  • 2023 International Congress

    Modulation of autophagy and neuroinflammation by Niclosamide in MPTP Induced- Parkinson’s disease model

    SHI. Kartik (Lucknow, India)

    Objective: The current investigation aimed to investigate the neuroprotective effect of niclosamide (NI) on autophagy and neuroinflammatory pathways in Parkinson’s disease (PD). Background: Autophagy dysregulation…
  • 2023 International Congress

    Use of insect model to study Parkinson’s disease pathophysiology by inducing GSH-depletion and behavioral deficits among larvae: Evidences of ameliorative properties of phytoconstituents

    G. Chandran, R. D'Silva, M. Muralidhara (MYSURU, India)

    Objective: The purpose of the study is to establish an all-around model for Parkinson's disease using Drosophila melanogaster, the fruit-fly in order to understand  behavioral…
  • 2023 International Congress

    Posturography as an objective measure of disease progression and prognostication in Progressive Supranuclear Palsy

    G. Nuebling, S. Katzdobler, J. Levin, G. Höglinger, S. Lorenzl (Munich, Germany)

    Objective: To determine the usefulness of posturography as an objective measure of disease progression and prognostication on Progressive Supranuclear Palsy (PSP). Background: To date, interventional…
  • « Previous Page
  • 1
  • …
  • 101
  • 102
  • 103
  • 104
  • 105
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • #25116 (not found)
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley